Liver X receptor and peroxisome proliferator-activated receptor agonist from Cornus alternifolia

被引:16
作者
He, Yang-Qing [1 ,2 ]
Ma, Guo-Yi [1 ]
Peng, Jiang-nan [3 ]
Ma, Zhan-Ying [2 ]
Hamann, Mark T. [1 ]
机构
[1] Univ Mississippi, Sch Pharm, Dept Pharmacognosy, University, MS 38677 USA
[2] Xian Univ Technol, Dept Appl Chem, Xian 710048, Peoples R China
[3] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA
来源
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS | 2012年 / 1820卷 / 07期
关键词
Peroxisome proliferator-activated receptors; Liver X receptors; Cornus alternifolia; Iridoid glycosides; IRIDOID GLUCOSIDES; ANTHOCYANINS; REQUIREMENTS; CONSTITUENTS; ANTIOXIDANT; MECHANISMS; PRINCIPLES; GLYCOSIDES; TARGETS; LEAVES;
D O I
10.1016/j.bbagen.2012.02.004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Peroxisome proliferator-activated receptors (PPARs) belong to the nuclear receptors superfamily and are transcription factors activated by specific ligands. Liver X receptors (LXR) belong to the nuclear hormone receptors and have been shown to play an important role in cholesterol homeostasis. From the previous screening of several medicinal plants for potential partial PPAR gamma agonists, the extracts of Cornus alternifolia were found to exhibit promising bioactivity. In this paper, we report the isolation and structural elucidation of four new compounds and their potential as ligands for PPAR. Methods: The new compounds were extracted from the leaves of C alternifolia and fractionated by high-performance liquid chromatography. Their structures were elucidated on the basis of spectroscopic evidence and analysis of their hydrolysis products. Results: Three new iridoid glycosides including an iridolactone, alternosides A-C (1-3), a new megastigmane glycoside, cornalternoside (4) and 10 known compounds, were obtained from the leaves of C alternifolia. Kaempferol-3-O-beta-glucopyranoside (5) exhibited potent agonistic activities for PPAR alpha, PPAR gamma and LXR with EC50 values of 0.62, 3.0 and 1.8 mu M, respectively. Conclusions: We isolated four new and ten known compounds from C. alternifolia, and one known compound showed agonistic activities for PPAR alpha, PPAR gamma and LXR. General significance: Compound 1 is the first example of a naturally occurring iridoid glycoside containing a beta-glucopyranoside moiety at C-6. Published by Elsevier B.V.
引用
收藏
页码:1021 / 1026
页数:6
相关论文
共 50 条
  • [41] Identification of Posttranslational Modifications in Peroxisome Proliferator-Activated Receptor γ Using Mass Spectrometry
    Katsura, Shogo
    Okumura, Tomoko
    Ito, Ryo
    Sugawara, Akira
    Yokoyama, Atsushi
    [J]. PPAR RESEARCH, 2014, 2014
  • [42] The peroxisome proliferator-activated receptor: A family of nuclear receptors role in various diseases
    Tyagi, Sandeep
    Gupta, Paras
    Saini, Arminder Singh
    Kaushal, Chaitnya
    Sharma, Saurabh
    [J]. JOURNAL OF ADVANCED PHARMACEUTICAL TECHNOLOGY & RESEARCH, 2011, 2 (04) : 236 - 240
  • [43] Pseudolaric acid analogs as a new class of peroxisome proliferator-activated receptor agonists
    Jardat, MS
    Noonan, DJ
    Wu, BG
    Avery, MA
    Feller, DR
    [J]. PLANTA MEDICA, 2002, 68 (08) : 667 - 671
  • [44] Downregulation of Peroxisome Proliferator-activated Receptor-γ Expression in Hypertensive Atrial Fibrillation
    Chen, Xiaoping
    Bing, Ziyi
    He, Jiyun
    Jiang, Lingyun
    Luo, Xiaojia
    Su, Yanling
    Kan, Bing
    Huang, Dejia
    Wei, Yuquan
    [J]. CLINICAL CARDIOLOGY, 2009, 32 (06) : 337 - 345
  • [45] Peroxisome Proliferator-activated Receptor Gamma in the Colon Inflammation and Innate Antimicrobial Immunity
    Speca, Silvia
    Dubuquoy, Laurent
    Desreumaux, Pierre
    [J]. JOURNAL OF CLINICAL GASTROENTEROLOGY, 2014, 48 : S23 - S27
  • [46] Peroxisome Proliferator-activated Receptor-γ Agonist Pioglitazone Ameliorates White Matter Lesion and Cognitive Impairment in Hypertensive Rats
    Lan, Lin-Fang
    Zheng, Lu
    Yang, Xian
    Ji, Xiao-Tan
    Fan, Yu-Hua
    Zeng, Jin-Sheng
    [J]. CNS NEUROSCIENCE & THERAPEUTICS, 2015, 21 (05) : 410 - 416
  • [47] CMHX008, a Novel Peroxisome Proliferator-Activated Receptor γ Partial Agonist, Enhances Insulin Sensitivity In Vitro and In Vivo
    Ming, Yue
    Hu, Xiangnan
    Song, Ying
    Liu, Zhiguo
    Li, Jibin
    Gao, Rufei
    Zhang, Yuyao
    Mei, Hu
    Guo, Tingwang
    Xiao, Ling
    Wang, Bochu
    Wu, Chaodong
    Xiao, Xiaoqiu
    [J]. PLOS ONE, 2014, 9 (07):
  • [48] Peroxisome proliferator-activated receptor a activation attenuates the inflammatory response to protect the liver from acute failure by promoting the autophagy pathway
    Jiao, M.
    Ren, F.
    Zhou, L.
    Zhang, X.
    Zhang, L.
    Wen, T.
    Wei, L.
    Wang, X.
    Shi, H.
    Bai, L.
    Zhang, X.
    Zheng, S.
    Zhang, J.
    Chen, Y.
    Han, Y.
    Zhao, C.
    Duan, Z.
    [J]. CELL DEATH & DISEASE, 2014, 5 : e1397 - e1397
  • [49] The Role of Peroxisome Proliferator-Activated Receptor in Mediating Cardioprotection Against Ischemia/Reperfusion Injury
    Zhong, Chong-Bin
    Chen, Xi
    Zhou, Xu-Yue
    Wang, Xian-Bao
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2018, 23 (01) : 46 - 56
  • [50] Peroxisome proliferator-activated receptor agonists and antagonists: a patent review (2014-present)
    Takada, Ichiro
    Makishima, Makoto
    [J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 2020, 30 (01) : 1 - 13